This compound is a protected peptide intermediate used in the manufacturing of carfilzomib, a pharmaceutical agent. It features a complex structure containing multiple amide bonds, an aromatic ring system, and a morpholine moiety.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 868540-16-3
(S)-Methyl 2-((S)-4-Methyl-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMido)-3-phenylpropanoate
Pharmaceutical intermediate for carfilzomib synthesis
L-Phenylalanine, (alphaS)-alpha-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-, phenylmethyl ester
research compound
Carfilzomib
active pharmaceutical ingredient
(S)-4-Methyl-N-((R)-1-(((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
pharmaceutical intermediate
5-chloro-2-picolinic acid
pharmaceutical intermediate
Acetyl octapeptide-3
Peptide synthesis intermediate
2-Chloro-N,N-diethylethanamine hydrochloride
pharmaceutical intermediate
4-Chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical Intermediate
(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid
MIVQDKORYUSPTQ-QKDODKLFSA-N
CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC2=CC=CC=C2)NC(=O)CN3CCOCC3